GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dae Hwa Pharm Co Ltd (XKRX:067080) » Definitions » Gross-Profit-to-Asset %

Dae Hwa Pharm Co (XKRX:067080) Gross-Profit-to-Asset % : 24.00% (As of Jun. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Dae Hwa Pharm Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Dae Hwa Pharm Co's annualized Gross Profit for the quarter that ended in Jun. 2024 was ₩52,083 Mil. Dae Hwa Pharm Co's average Total Assets over the quarter that ended in Jun. 2024 was ₩217,033 Mil. Therefore, Dae Hwa Pharm Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2024 was 24.00%.


Dae Hwa Pharm Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Dae Hwa Pharm Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dae Hwa Pharm Co Gross-Profit-to-Asset % Chart

Dae Hwa Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.63 25.07 24.78 24.49 21.71

Dae Hwa Pharm Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.49 18.05 20.45 21.05 24.00

Competitive Comparison of Dae Hwa Pharm Co's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Dae Hwa Pharm Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dae Hwa Pharm Co's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dae Hwa Pharm Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Dae Hwa Pharm Co's Gross-Profit-to-Asset % falls into.



Dae Hwa Pharm Co Gross-Profit-to-Asset % Calculation

Dae Hwa Pharm Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=45406.144/( (199056.473+219162.617)/ 2 )
=45406.144/209109.545
=21.71 %

Dae Hwa Pharm Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Jun. 2024 )/( (Total Assets (Q: Mar. 2024 )+Total Assets (Q: Jun. 2024 ))/ count )
=52082.868/( (219185.455+214880.636)/ 2 )
=52082.868/217033.0455
=24.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Jun. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Dae Hwa Pharm Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Dae Hwa Pharm Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Dae Hwa Pharm Co Business Description

Traded in Other Exchanges
N/A
Address
495 Hanu-ro, Hoengseong-eup, Hoengseong-gun, Seoul, Gangwon-do, KOR, 225-804
Dae Hwa Pharm Co Ltd is a specialized pharmaceutical company. It is mainly involved in manufacturing and distribution of pharmaceutical products. The company controls approximately 70% of the domestic transdermal drug delivery system market. The company offers analgesics and anti-inflammatory drugs, antihistamines, skeletal muscle relaxants, and cardiovascular drugs. Its products are exported to Asia, South America, Africa, and the Middle East.

Dae Hwa Pharm Co Headlines

No Headlines